Search Results - "Ongini, E"

Refine Results
  1. 1

    Nitric oxide‐donating statin improves multiple functions of circulating angiogenic cells by Mangialardi, G, Monopoli, A, Ongini, E, Spinetti, G, Fortunato, O, Emanueli, C, Madeddu, P

    Published in British journal of pharmacology (01-09-2011)
    “…BACKGROUND AND PURPOSE Statins, a major component of the prevention of cardiovascular disease, aid progenitor cell functions in vivo and in vitro. Statins…”
    Get full text
    Journal Article
  2. 2

    Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type‐1 diabetic mice by Emanueli, C, Monopoli, A, Kraenkel, N, Meloni, M, Gadau, S, Campesi, I, Ongini, E, Madeddu, P

    Published in British journal of pharmacology (01-04-2007)
    “…Background and purpose: Mature endothelial cells and their progenitors are dysfunctional in diabetes, resulting in deficient neovascularisation following…”
    Get full text
    Journal Article
  3. 3

    A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs by Impagnatiello, F., Borghi, V., Gale, D.C., Batugo, M., Guzzetta, M., Brambilla, S., Carreiro, S.T., Chong, W.K.M., Prasanna, G., Chiroli, V., Ongini, E., Krauss, A.H.P.

    Published in Experimental eye research (01-09-2011)
    “…The IOP lowering effects of NCX 139, a new chemical entity comprising latanoprost amide and a NO-donating moiety, were compared to those of the respective…”
    Get full text
    Journal Article
  4. 4
  5. 5

    P.11.3 Long term treatment with naproxcinod significantly improves skeletal and cardiac function in mdx mouse model of dystrophy by Nagaraju, K, Uaesoontrachoon, K, Quinn, J, Tatem, K, Creeden, B, Vandermeulen, J, Yu, Q, Gordish, H, Ongini, E, Miglietta, D

    Published in Neuromuscular disorders : NMD (01-10-2013)
    “…There is evidence that nitric oxide (NO) plays a critical role in skeletal muscle. In Duchenne muscular dystrophy (DMD) patients and the mdx mouse model of…”
    Get full text
    Journal Article
  6. 6

    Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury by Briscini, Luca, Corradini, Laura, Ongini, Ennio, Bertorelli, Rosalia

    Published in European journal of pharmacology (28-06-2002)
    “…Nociceptin, acting through the opioid receptor-like 1 (ORL1) receptor, produces anti-nociception in several models of neuropathy. We examined the involvement…”
    Get full text
    Journal Article
  7. 7

    A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model by Galassi, F, Masini, E, Giambene, B, Fabrizi, F, Uliva, C, Bolla, M, Ongini, E

    Published in British journal of ophthalmology (01-11-2006)
    “…Background: Topical nitric oxide-releasing dexamethasone (NCX1021) may avoid the negative effects of dexamethasone phosphate. Aims: To obtain more information…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression by Rossiello, M R, Momi, S, Caracchini, R, Giannini, S, Guglielmini, G, Monopoli, A, Ongini, E, Semeraro, N, Colucci, M, Gresele, P

    Published in Journal of thrombosis and haemostasis (01-11-2005)
    “…NO-releasing statins are new chemical entities, combining HMG-CoA reductase inhibition and slow NO release, that possess stronger anti-inflammatory and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors by Ongini, E, Dionisotti, S, Gessi, S, Irenius, E, Fredholm, B B

    “…Three structurally related non-xanthine compounds, CGS 15943, ZM 241385 and SCH 58261, are potent A2A adenosine receptor antagonists and have been used as…”
    Get full text
    Journal Article
  12. 12

    The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist by Zocchi, C, Ongini, E, Conti, A, Monopoli, A, Negretti, A, Baraldi, P G, Dionisotti, S

    “…We have characterized the in vitro pharmacological profile of the new potent and selective A2a adenosine receptor antagonist SCH 58261…”
    Get more information
    Journal Article
  13. 13

    Presenilin-1 Regulates the Neuronal Threshold to Excitotoxicity Both Physiologically and Pathologically by Grilli, M., Diodato, E., Lozza, G., Brusa, R., Casarini, M., Uberti, D., Rozmahel, R., Westaway, D., St George-Hyslop, P., Memo, M., Ongini, E.

    “…A direct pathophysiological role of Familial Alzheimer's Disease (FAD)-associated Presenilin 1 (PS1) mutations in neuronal vulnerability remains a…”
    Get full text
    Journal Article
  14. 14

    Inhibitory Effect of NO-Releasing Ciprofloxacin (NCX 976) on Mycobacterium tuberculosis Survival by CICCONE, R, MARIANI, F, CAVONE, A, PERSICHINI, T, VENTURINI, G, ONGINI, E, COLIZZI, V, COLASANTI, M

    Published in Antimicrobial Agents and Chemotherapy (01-07-2003)
    “…ERRATUM ( vol. 48 , p. 368 ) Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
    Get full text
    Journal Article
  15. 15

    Nociceptin and the ORL‐1 ligand [Phe1ψ (CH2‐NH)Gly2]nociceptin(1‐13)NH2 exert anti‐opioid effects in the Freund's adjuvant‐induced arthritic rat model of chronic pain by Bertorelli, Rosalia, Corradini, Laura, Rafiq, Kamran, Tupper, Joanna, Calò, Girolamo, Ongini, Ennio

    Published in British journal of pharmacology (01-11-1999)
    “…Stimulation of the opioid receptor‐like1 (ORL‐1) receptor by nociceptin (NC) produces hyperalgesia and reverses the antinociceptive effects induced by opioids…”
    Get full text
    Journal Article
  16. 16

    Lack of the nociceptin receptor does not affect acute or chronic nociception in mice by Bertorelli, Rosalia, Bastia, Elena, Citterio, Francesca, Corradini, Laura, Forlani, Angelo, Ongini, Ennio

    Published in Peptides (New York, N.Y. : 1980) (01-09-2002)
    “…The peptide nociceptin/orphanin FQ (N/OFQ) and its receptor ORL-1, also designated opioid receptor 4 (OP 4) are involved in the modulation of nociception…”
    Get full text
    Journal Article
  17. 17

    Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes by Zocchi, Cristina, Ongini, Ennio, Ferrara, Silvia, Baraldi, Pier Giovanni, Dionisotti, Silvio

    Published in British journal of pharmacology (01-04-1996)
    “…1 The present study describes the binding to rat striatal A2A adenosine receptors of the new potent and selective antagonist radioligand,…”
    Get full text
    Journal Article
  18. 18

    Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat by Ongini, E, Bonizzoni, E, Ferri, N, Milani, S, Trampus, M

    “…A series of antipsychotics having different selectivity for dopamine (DA) D-1 and D-2 receptors were studied for their effects on sleep stages in the rat…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis by Wallace, John L, Syer, Stephanie, Denou, Emmanuel, de Palma, Giada, Vong, Linda, McKnight, Webb, Jury, Jennifer, Bolla, Manlio, Bercik, Premysl, Collins, Stephen M, Verdu, Elena, Ongini, Ennio

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2011)
    “…Background & Aims Proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used classes of drugs, with the…”
    Get full text
    Journal Article